首页 › 基金 › Palo Alto Investors LP › PYXS
Palo Alto Investors LP 对 PYXS 的持仓历史
PYXIS ONCOLOGY INC · 医疗保健
Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 PYXS(PYXIS ONCOLOGY INC)864,277 股,市值约 US$2.0M,约占其申报组合的 0.30%,在其申报持仓中市值排名第 40 位。 Palo Alto Investors LP 最近 9 个申报季度中有 9 个季度披露了 PYXS 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Palo Alto Investors LP 对 PYXS 的持仓演变
Palo Alto Investors LP 于 Q3 2024 首次披露 PYXS 持仓:170,000 股(约 US$624K)。 该持仓在 Q2 2026 达到峰值 864,277 股,市值约 US$2.6M。 在 9 次申报中,Palo Alto Investors LP 1 次增持、2 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 864,277 股、市值约 US$2.0M。 持仓曾出现大幅变动:Q4 2024 增持约 510% (随后一个季度股价下跌 37%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 170.00K | $623.90K | 新进 |
| Q4 2024 | 1.04M | $1.62M | 增持 |
| Q1 2025 | 1.04M | $1.02M | 持有 |
| Q2 2025 | 1.04M | $1.14M | 持有 |
| Q3 2025 | 1.04M | $2.30M | 持有 |
| Q4 2025 | 1.04M | $1.19M | 持有 |
| Q1 2026 | 1.01M | $1.48M | 减持 |
| Q2 2026 | 864.28K | $2.60M | 减持 |
| Q3 2026 | 864.28K | $2.01M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PYXS 与 13F 数据
PYXS(PYXIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 PYXS,申报仓位最大的包括:GordonMD Global Investments LP (US$36.2M), BVF INC/IL (US$27.6M), PFIZER INC (US$20.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PYXS 的基金
- GordonMD Global Investments LP 15.54M 股 · $36.21M · Q3 2026
- BVF INC/IL 11.83M 股 · $27.55M · Q3 2026
- PFIZER INC 7.03M 股 · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M 股 · $11.63M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 1.25M 股 · $2.91M · Q3 2026
- Blue Owl Capital Holdings LP 1.00M 股 · $2.33M · Q3 2026
- Empery Asset Management, LP 1.00M 股 · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K 股 · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K 股 · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K 股 · $761.47K · Q3 2026
- Monashee Investment Management LLC 229.31K 股 · $534.29K · Q3 2026
更多关于 Palo Alto Investors LP
常见问题
How long has Palo Alto Investors LP held PYXS?
Palo Alto Investors LP has disclosed PYXS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Palo Alto Investors LP's current position in PYXS?
As of Q3 2026, Palo Alto Investors LP holds 864.28K shares of PYXS (PYXIS ONCOLOGY INC), valued at $2.01M, representing 0.30% of its reported portfolio and ranking #40.
Has Palo Alto Investors LP been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in PYXS. The position peaked in Q2 2026 at 864.28K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, BVF INC/IL, PFIZER INC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.